Kyowa Kirin Co Ltd's Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Total-Revenue" stands at 493.24 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.
Kyowa Kirin Co Ltd's second quarter result of 125.93 Billion JPY for the item "Total Revenue" represents an increase of 20.25 percent compared to it's first quarter result.
Also, Kyowa Kirin Co Ltd's second quarter result of 125.93 Billion JPY for the item "Total Revenue" represents a decrease of -1.16 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Kyowa Kirin Co Ltd's second quarter result of 493.24 Billion JPY for the item "Total Revenue" represents a decrease of -0.3 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 3.62 percent compared to the value the year prior.
The 1 year change in percent is 3.62.
The 3 year change in percent is 32.41.
The 5 year change in percent is 57.98.
The 10 year change in percent is 40.77.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Revenue | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Revenue | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Revenue | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Revenue | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Revenue | 280,205,508,085.11 |